| Financial Year |
March 31 2022 |
| Monetary Funds |
28,197,699.42 |
| Held-for-trading Financial Assets |
720,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,363,958.85 |
| Advances to Suppliers |
6,214,234.88 |
| Other Receivables |
4,065,637.60 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,168,512.58 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
4,713,095.82 |
| Other Current Assets |
-- |
| Total Current Assets |
765,723,139.15 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
272,965,115.57 |
| Investment Properties |
11,898,516.90 |
| Fixed Assetes |
9,744,853.68 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
95,045,238.24 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
408,665,158.57 |
| Total Assets |
1,174,388,297.72 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
8,564,098.20 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
20,773,543.55 |
| Taxes Payable |
10,556,408.19 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
70,801,298.24 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,286,523.02 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
112,981,871.20 |
| Long-term Loans |
6,195,249.61 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
231,090,856.15 |
| Total Liabilities |
344,072,727.35 |
| Paid-In Capital(Or Share Stock) |
437,412,524.00 |
| Capital Surplus |
1,670,379,323.05 |
| Surplus Reserve |
64,430,830.87 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,344,662,264.37 |
| Minority Stockholder's Interest |
2,755,156.82 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
827,560,413.55 |
| Owner's Equity（Stockholder's Equity） |
830,315,570.37 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,174,388,297.72 |
